Passage Bio (PASG) Earnings Analysis
Passage Bio (PASG) next reports earnings on 2026-08-11, consensus EPS -2.64667 USD. Last quarter (2026-03-03) it missed with EPS -4.08 USD vs -2.19 USD est (-86.3%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E -0.42.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PASG next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -2.64667 USD |
| Revenue estimate | n/a |
PASG earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | -4.08 USD | -2.19 USD | -86.3% | Miss |
| 2025-11-10 | -2.44 USD | -2.64 USD | +7.6% | Beat |
| 2025-08-12 | -2.96 USD | -4 USD | +26% | Beat |
| 2025-03-04 | -0.2 USD | -0.21 USD | +4.8% | Beat |
| 2024-08-08 | -0.26 USD | -0.31 USD | +16.1% | Beat |
Beat rate: 4/5 (80%) over reported quarters with consensus data.
PASG valuation and analyst view
| Trailing P/E | -0.42 |
|---|---|
| Trailing EPS | -11.75221 USD |
| Price / book | 1.34 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (6 buy / 5 hold / 0 sell) |
| Avg price target | 10 USD |
Related research pages
Frequently asked questions
When is Passage Bio (PASG)'s next earnings date?
Passage Bio is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -2.64667 USD.
Did PASG beat earnings last quarter?
In its 2026-03-03 report, PASG posted EPS of -4.08 USD versus a -2.19 USD estimate — a miss of 86.3%.
What is PASG's earnings track record?
Over the last 5 reported quarters with consensus data, PASG beat estimates 4 times (80%).
What is PASG's current P/E ratio and EPS?
PASG trades at a trailing P/E of -0.42 on trailing EPS of -11.75220673602702 USD.
What do analysts rate PASG?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 6 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 10 USD.